Literature DB >> 11563551

Mdx myotubes have normal excitability but show reduced contraction-relaxation dynamics.

V Nicolas-Metral1, E Raddatz, P Kucera, U T Ruegg.   

Abstract

The pathogenesis of Duchenne muscular dystrophy (DMD), characterised by lack of the cytoskeletal protein dystrophin, is not completely understood. An early event in the degenerative process of DMD muscle could be a rise in cytosolic calcium concentration. In order to investigate whether this leads to alterations of contractile behaviour, we studied the excitability and contractile properties of cultured myotubes from control (C57BL/10) and mdx mice, an animal model for DMD. The myotubes were stimulated electrically and their motion was recorded photometrically. No significant differences were found between control and mdx myotubes with respect to the following parameters: chronaxy and rheobase (0.33 +/- 0.03 ms and 23 +/- 4 V vs. 0.39 +/- 0.07 ms and 22 +/- 2 V for C57 and mdx myotubes, respectively), tetanisation frequency (a similar distribution pattern was found between 5 and 30 Hz), fatigue during tetanus (found in 35% of both types of myotubes) and post-tetanic contracture. In contrast, contraction and relaxation times were longer (P < 0.005) in mdx (36 +/- 2 and 142 +/- 13 ms, respectively) than in control myotubes (26 +/- 1 and 85 +/- 9 ms, respectively). Together with our earlier findings, these results suggest a decreased capacity for calcium removal in mdx cells leading, in particular, to alterations of muscle relaxation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11563551     DOI: 10.1023/a:1010384625954

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  43 in total

1.  Peroxynitrite modification of protein thiols: oxidation, nitrosylation, and S-glutathiolation of functionally important cysteine residue(s) in the sarcoplasmic reticulum Ca-ATPase.

Authors:  R I Viner; T D Williams; C Schöneich
Journal:  Biochemistry       Date:  1999-09-21       Impact factor: 3.162

2.  Hypoosmotic shocks induce elevation of resting calcium level in Duchenne muscular dystrophy myotubes contracting in vitro.

Authors:  N Imbert; C Vandebrouck; B Constantin; G Duport; C Guillou; C Cognard; G Raymond
Journal:  Neuromuscul Disord       Date:  1996-10       Impact factor: 4.296

3.  Expression of chloride channel 1 mRNA in cultured myogenic cells: a marker of myotube maturation.

Authors:  C Bardouille; D Vullhorst; H Jockusch
Journal:  FEBS Lett       Date:  1996-11-04       Impact factor: 4.124

4.  Electrical properties of diaphragm and EDL muscles during the life of dystrophic mice.

Authors:  A De Luca; S Pierno; D C Camerino
Journal:  Am J Physiol       Date:  1997-01

5.  A critical evaluation of resting intracellular free calcium regulation in dystrophic mdx muscle.

Authors:  F W Hopf; P R Turner; W F Denetclaw; P Reddy; R A Steinhardt
Journal:  Am J Physiol       Date:  1996-10

6.  Regulation of cytosolic calcium in skeletal muscle cells of the mdx mouse under conditions of stress.

Authors:  W J Leijendekker; A C Passaquin; L Metzinger; U T Rüegg
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

7.  Increased calcium entry into dystrophin-deficient muscle fibres of MDX and ADR-MDX mice is reduced by ion channel blockers.

Authors:  O Tutdibi; H Brinkmeier; R Rüdel; K J Föhr
Journal:  J Physiol       Date:  1999-03-15       Impact factor: 5.182

8.  Time course study of the isometric contractile properties of mdx mouse striated muscles.

Authors:  C Pastoret; A Sebille
Journal:  J Muscle Res Cell Motil       Date:  1993-08       Impact factor: 2.698

Review 9.  Interaction of reactive oxygen species with ion transport mechanisms.

Authors:  J I Kourie
Journal:  Am J Physiol       Date:  1998-07

10.  Myotubes from transgenic mdx mice expressing full-length dystrophin show normal calcium regulation.

Authors:  W F Denetclaw; F W Hopf; G A Cox; J S Chamberlain; R A Steinhardt
Journal:  Mol Biol Cell       Date:  1994-10       Impact factor: 4.138

View more
  7 in total

1.  Genetic inhibition of PKA phosphorylation of RyR2 prevents dystrophic cardiomyopathy.

Authors:  Satyam Sarma; Na Li; Ralph J van Oort; Corey Reynolds; Darlene G Skapura; Xander H T Wehrens
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-06       Impact factor: 11.205

2.  Hsp72 preserves muscle function and slows progression of severe muscular dystrophy.

Authors:  Stefan M Gehrig; Chris van der Poel; Timothy A Sayer; Jonathan D Schertzer; Darren C Henstridge; Jarrod E Church; Severine Lamon; Aaron P Russell; Kay E Davies; Mark A Febbraio; Gordon S Lynch
Journal:  Nature       Date:  2012-04-04       Impact factor: 49.962

3.  Lipogenesis mitigates dysregulated sarcoplasmic reticulum calcium uptake in muscular dystrophy.

Authors:  Christopher W Paran; Kai Zou; Patrick J Ferrara; Haowei Song; John Turk; Katsuhiko Funai
Journal:  Biochim Biophys Acta       Date:  2015-09-08

4.  Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy.

Authors:  J Reutenauer; O M Dorchies; O Patthey-Vuadens; G Vuagniaux; U T Ruegg
Journal:  Br J Pharmacol       Date:  2008-07-21       Impact factor: 8.739

Review 5.  Genetic evidence in the mouse solidifies the calcium hypothesis of myofiber death in muscular dystrophy.

Authors:  A R Burr; J D Molkentin
Journal:  Cell Death Differ       Date:  2015-06-19       Impact factor: 15.828

6.  Effects of an immunosuppressive treatment in the GRMD dog model of Duchenne muscular dystrophy.

Authors:  Inès Barthélémy; Ane Uriarte; Carole Drougard; Yves Unterfinger; Jean-Laurent Thibaud; Stéphane Blot
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

7.  Blockade of IGF2R improves muscle regeneration and ameliorates Duchenne muscular dystrophy.

Authors:  Pamela Bella; Andrea Farini; Stefania Banfi; Daniele Parolini; Noemi Tonna; Mirella Meregalli; Marzia Belicchi; Silvia Erratico; Pasqualina D'Ursi; Fabio Bianco; Mariella Legato; Chiara Ruocco; Clementina Sitzia; Simone Sangiorgi; Chiara Villa; Giuseppe D'Antona; Luciano Milanesi; Enzo Nisoli; PierLuigi Mauri; Yvan Torrente
Journal:  EMBO Mol Med       Date:  2019-12-02       Impact factor: 12.137

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.